Vaccination against Cervical Cancer: Profile of Accommodating Parents and Some Suggestions to Overcome Hesitancy against Vaccination

References (25)

1. 1 Human papillomavirus is a necessary cause of invasive cervical cancer worldwide [DOI]
2. 2 Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis [DOI]
3. 3 Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication [DOI]
4. 4 The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV‐Naive Women Aged 16–26 Years [DOI]
5. 5 Vaccine hesitancy around the globe: Analysis of three years of WHO/UNICEF Joint Reporting Form data-2015–2017 [DOI]
6. 6 Worldwide trends in cervical cancer incidence: Impact of screening against changes in disease risk factors [DOI]
7. 7 Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection.
8. 8 A global view on cancer incidence and national levels of the human development index [DOI]
9. 9 The precision prevention and therapy of HPV ‐related cervical cancer: new concepts and clinical implications [DOI]
10. 10 Cervical Cancer Prevalence, Incidence and Mortality in Low and Middle Income Countries: A Systematic Review [DOI]
11. 11 Epidemiology and burden of HPV infection and related diseases: Implications for prevention strategies [DOI]
12. 12 Status of HPV vaccine introduction and barriers to country uptake [DOI]
13. 13 Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study [DOI]
14. 14 Educational Interventions for Cervical Cancer Screening Behavior of Women: A Systematic Review [DOI]
15. 15 Female human papillomavirus (HPV) vaccination: Global uptake and the impact of attitudes [DOI]
16. 16 Scaling up proven innovative cervical cancer screening strategies: Challenges and opportunities in implementation at the population level in low‐ and lower‐middle‐income countries [DOI]
17. 17 Ethnic differences in human papillomavirus awareness and vaccine acceptability [DOI]
18. 18 Cervical cancer prevention: safety, acceptability, and feasibility of a single-visit approach in Accra, Ghana [DOI]
19. 19 Social mobilisation, consent and acceptability: a review of human papillomavirus vaccination procedures in low and middle-income countries [DOI]
20. 20 Cancer Burden and Control in the Western Pacific Region: Challenges and Opportunities [DOI]
21. 21 Analyzing Awareness on Risk Factors, Barriers and Prevention of Cervical Cancer among Pairs of Nepali High School Students and Their Mothers [DOI]
22. 22 How Should Cervical Cancer Prevention Be Improved in LMICs? [DOI]
23. 23 Gynecologic procedures: colposcopy, treatments for cervical intraepithelial neoplasia and endometrial assessment.
24. 24 Same day colposcopic examination and loop electrosurgical excision procedure (LEEP) presents minimal overtreatment and averts delay in treatment of cervical intraepithelial neoplasia in Kenyatta National Hospital, Kenya [DOI]
25. 25 Effects of Application of Social Marketing Theory and the Health Belief Model in Promoting Cervical Cancer Screening among Targeted Women in Sisaket Province, Thailand [DOI]

Cited by 1

Related research

• A Statistical Approach towards Cervical Cancer Awareness among Women in Ghana — shares topic coverage
• Experiences of Women Living with Cervical Cancer: A Study in the Tamale Metropolis — shares topic coverage
• Retrospective Analysis of Cancer Cervix at Awal Bros Batam Hospital in 2020-2022 — shares topic coverage
• Sequence Variations of Human Papillomavirus Type 16 E6 and E7 Genes in Cervical Cancer Isolates from Gabon — shares topic coverage
• Molecular Characterization of HPV16 E6 and E7 Variants among Women with Cervical Cancer in Morocco — shares topic coverage